FDA starts pilot scheme to enhance the security of medicine imports
A US FDA pilot project aimed at enhancing the security of imported medicines has got underway. The programme should allow the agency to focus its surveillance efforts on high-risk shipments that are most likely to be adulterated or counterfeit, whilst cutting red tape and delays for low-risk imports.
Up to 40% of the drugs Americans take are manufactured outside US borders, while 80% of the active pharmaceutical ingredients come from foreign sources. It is widely recognised that the FDA will never have the capacity to screen all imported drug shipments so the new risk-based approach should help it direct resources most effectively (Website Securing Industry, 20 February 2014).
Click here for the full article.
This item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: email@example.com, +31-(0)182-512411.